Drug-resistant sub-lines of A375 that are BRAF^V600E and NRAS WT
| Inventor | Institute |
|---|---|
| Christoper Stipp | University Of Iowa Research Foundation |
| SKU: | 161790 |
|---|---|
| Product description: | Drug-resistant sub-lines of A375 that are BRAF^V600E and NRAS WT. VEM-resistant derivative of A375. Shows Increased VAV1 protein levels. Showed decreased MEK Phosphorylation on S217(Raf Site) and Increased MEK Phosphorylation on S298 (Pak Site). |
| Alternate name: | vRRP2 |
| Gender: | Female |
| Production details: | Spontaneous vemurafenib-resistant clones and populations were created after 23 and 46 weeks cultured in 3 mm vemurafenib. maintained in media with 3 mm vemurafenib. |
| Parental cell line: | A375 Melanoma (ATCC) |
| Cat. #: | 161790 |
|---|---|
| Cancer types: | Skin cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Skin |
| Gender: | Female |
| Morphology: | Diffuse Morphology |
| Primary citation: | Feddersen et al.2019. Cancer Res. 79(19).PMID: 31416844 |
| Shipping conditions: | Dry Ice |
|---|---|
| Growth medium: | DMEM(Gibco) suplemented with penicillin/streptomycin (Gibco) and 10% FBS (Gibco). |
| References: |
Feddersen et al.2019. Cancer Res. 79(19).PMID: 31416845 Zhu et al. 2022. npj Precis. Onc. PMID: 36271142 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.